2-三丁基甲锡烷基噻唑 | 121359-48-6

• 分子结构分类: 有机化合物 - 有机金属化合物 - 金属芳基
• 中文名称: 2-三丁基甲锡烷基噻唑
• 中文别名: 2-(三丁基锡烷基)噻唑；2-(三正丁基甲锡烷基)噻唑；2-(三正丁基甲锡烷基)噻唑,96%
• 英文名称: 2-(tri-n-butylstannyl)thiazole
• 英文别名: 2-(tributylstannyl)thiazole；tributyl(thiazol-2-yl)stannane；2-(tributylstannyl)-1,3-thiazole；2-tributylstannanylthiazole；2-(tributylstannanyl)-1,3-thiazole；2-(1,1,1-tributylstannyl)-1,3-thiazole；tributyl(1,3-thiazol-2-yl)stannane；2-(tributyltinyl)-1,3-thiazole；tributyl(thiazol-2-yl)tin；tributyl(2-thiazolyl)tin
• CAS: 121359-48-6
• 化学式: C₁₅H₂₉NSSn
• 分子量: 374.178
• InChiKey: WUOFQGMXQCSPPV-UHFFFAOYSA-N

物化性质

• 熔点：
  224-225℃
• 沸点：
  307-309 °C(lit.)
• 密度：
  1.1900 g/mL at 25 °C(lit.)
• 闪点：
  >230 °F
• 溶解度：
  不可混溶或难以混合。
• 稳定性/保质期：
  常温常压下性质稳定，避免与强氧化剂和强矿物酸接触。

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  18
• 可旋转键数：
  10
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  41.1
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT, KEEP COLD, TOXIC
• 危险等级：
  6.1
• 危险品标志：
  T,N
• 安全说明：
  S35,S36/37/39,S45,S60,S61
• 危险类别码：
  R21
• 海关编码：
  2934100090
• WGK Germany：
  3
• 危险标志：
  GHS06,GHS08,GHS09
• 危险品运输编号：
  UN 2788 6.1/PG 2
• 危险性描述：
  H301,H312,H315,H319,H372,H400
• 危险性防范说明：
  P273,P280,P301 + P310,P305 + P351 + P338,P314
• 储存条件：
  密封保存。

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product name : 2-Tributylstannylthiazole

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
According to Regulation (EC) No1272/2008
Acute toxicity, Dermal (Category 4)
Acute toxicity, Oral (Category 3)
Skin irritation (Category 2)
Eye irritation (Category 2)
Specific target organ toxicity - repeated exposure (Category 1)
Acute aquatic toxicity (Category 1)
According to European Directive 67/548/EEC as amended.
Toxic if swallowed. Toxic: danger of serious damage to health by prolonged exposure through inhalation and if
swallowed. Harmful in contact with skin. Irritating to eyes and skin. Very toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.
Label elements
Pictogram
Signal word Danger
Hazard statement(s)
H301 Toxic if swallowed.
H312 Harmful in contact with skin.
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H372 Causes damage to organs through prolonged or repeated exposure.
H400 Very toxic to aquatic life.
Precautionary statement(s)
P273 Avoid release to the environment.
P280 Wear protective gloves/protective clothing.
P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER or
doctor/physician.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
P314 Get medical advice/attention if you feel unwell.
Hazard symbol(s)
T Toxic
N Dangerous for the environment
R-phrase(s)
R21 Harmful in contact with skin.
R25 Toxic if swallowed.
R36/38 Irritating to eyes and skin.
R48/23/25 Toxic: danger of serious damage to health by prolonged exposure through
inhalation and if swallowed.
R50/53 Very toxic to aquatic organisms, may cause long-term adverse effects in
the aquatic environment.
S-phrase(s)
S35 This material and its container must be disposed of in a safe way.
S36/37/39 Wear suitable protective clothing, gloves and eye/face protection.
S45 In case of accident or if you feel unwell, seek medical advice immediately
(show the label where possible).
S60 This material and its container must be disposed of as hazardous waste.
S61 Avoid release to the environment. Refer to special instructions/ Safety data
sheets.
Other hazards - none

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Formula : C15H29NSSn
Molecular Weight : 374,17 g/mol
CAS-No. EC-No. Index-No. Classification Concentration
2-Tributylstannylthiazole
121359-48-6 - 050-008-00-3 Acute Tox. 4; Acute Tox. 3; -
Skin Irrit. 2; Eye Irrit. 2; STOT
RE 1; Aquatic Acute 1; H301,
H312, H315, H319, H372,
H400
T, N, R21 - R25 - R36/38 -
R48/23/25 - R50/53
For the full text of the H-Statements mentioned in this Section, see Section 16.

---

Section 4. FIRST AID MEASURES
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing give artificial respiration Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.

---

Section 5. FIRE-FIGHTING MEASURES
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special protective equipment for fire-fighters
Wear self contained breathing apparatus for fire fighting if necessary.

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions
Use personal protective equipment. Avoid breathing vapors, mist or gas. Ensure adequate ventilation.
Evacuate personnel to safe areas.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the
environment must be avoided.
Methods and materials for containment and cleaning up
Soak up with inert absorbent material and dispose of as hazardous waste. Keep in suitable, closed
containers for disposal.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid inhalation of vapour or mist.
Normal measures for preventive fire protection.
Conditions for safe storage
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are
opened must be carefully resealed and kept upright to prevent leakage.

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Personal protective equipment
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator with
multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup to
engineering controls. If the respirator is the sole means of protection, use a full-face supplied air
respirator. Use respirators and components tested and approved under appropriate government
standards such as NIOSH (US) or CEN (EU).
Hand protection
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the
standard EN 374 derived from it.
Handle with gloves.
Eye protection
Face shield and safety glasses
Skin and body protection
Choose body protection according to the amount and concentration of the dangerous substance at the
work place.
Hygiene measures
Avoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling the
product.

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Appearance
Form liquid
Colour colourless
Safety data
pH no data available
Melting point no data available
Boiling point 307 - 309 °C - lit.
Flash point > 110 °C - closed cup
Ignition temperature no data available
Lower explosion limit no data available
Upper explosion limit no data available
Density 1,19 g/cm3 at 25 °C
Water solubility no data available

---

Section 10. STABILITY AND REACTIVITY
Chemical stability
Stable under recommended storage conditions.
Conditions to avoid
no data available
Materials to avoid
Strong oxidizing agentsStrong oxidizing agents, Strong mineral acids, Bases
Hazardous decomposition products
Hazardous decomposition products formed under fire conditions. - Carbon oxides, nitrogen oxides (NOx),
Sulphur oxides, Tin/tin oxides

---

Section 11. TOXICOLOGICAL INFORMATION
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
Causes damage to organs through prolonged or repeated exposure.
Aspiration hazard
no data available
Potential health effects
Inhalation Toxic if inhaled. May cause respiratory tract irritation.
Ingestion Toxic if swallowed.
Skin
Harmful if absorbed through skin. Causes skin irritation.
Eyes Causes eye irritation.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly
investigated.
Additional Information
RTECS: no data available

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
PBT and vPvB assessment
no data available
Other adverse effects
Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.

---

Section 13. DISPOSAL CONSIDERATIONS
Product
Observe all federal, state, and local environmental regulations. Contact a licensed professional waste
disposal service to dispose of this material. Dissolve or mix the material with a combustible solvent and burn
in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
ADR/RID
UN-Number: 2788 Class: 6.1 Packing group: II
Proper shipping name: ORGANOTIN COMPOUND, LIQUID, N.O.S. (2-Tributylstannylthiazole)
IMDG
UN-Number: 2788 Class: 6.1 Packing group: II EMS-No: F-A, S-A
Proper shipping name: ORGANOTIN COMPOUND, LIQUID, N.O.S. (2-Tributylstannylthiazole)
Marine pollutant: Marine pollutant
IATA
UN-Number: 2788 Class: 6.1 Packing group: II
Proper shipping name: Organotin compound, liquid, n.o.s. (2-Tributylstannylthiazole)

---

Section 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.

---

Section 16. OTHER INFORMATION
Text of H-code(s) and R-phrase(s) mentioned in Section 3
Acute Tox. Acute toxicity
Aquatic Acute Acute aquatic toxicity
Eye Irrit. Eye irritation
H301 Toxic if swallowed.
H312 Harmful in contact with skin.
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H372 Causes damage to organs through prolonged or repeated exposure.
H400 Very toxic to aquatic life.
Skin Irrit. Skin irritation
STOT RE Specific target organ toxicity - repeated exposure
N Dangerous for the environment
T Toxic
R21 Harmful in contact with skin.
R25 Toxic if swallowed.
R36/38 Irritating to eyes and skin.
R48/23/25 Toxic: danger of serious damage to health by prolonged exposure through inhalation
and if swallowed.
R50/53 Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic
environment.
Further information
Copyright 2010 Co. License granted to make unlimited paper copies for internal use only.
The above information is believed to be correct but does not purport to be all inclusive and shall be used
only as a guide. The information in this document is based on the present state of our knowledge and is
applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee
of the properties of the product. Co., shall not be held liable for any damage resulting from
handling or from contact with the above product. See reverse side of invoice or packing slip for additional
terms and conditions of sale.

制备方法与用途

用途：通过Stille交叉偶联反应实现噻唑芳基化。

反应信息

• 作为反应物：
  描述：

  2-三丁基甲锡烷基噻唑 生成 2-{8-chloro-6-[3-(4-fluorophenyl)-1-trityl-1H-4-pyrazolyl]imidazo[1,2-a]pyridin-3-yl}-1,3-thiazole
  参考文献：
  名称：

  NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF

  摘要：

  公开号：

  EP1382603B1
• 作为产物：
  描述：

  三丁基氯化锡 在 正丁基锂 、 sodium hydroxide 作用下， 以 乙醚 、 正己烷 、 水 为溶剂， 反应 1.5h， 生成 2-三丁基甲锡烷基噻唑
  参考文献：
  名称：

  [EN] HETEROCYCLIC COMPOUNDS
  [FR] COMPOSES HETEROCYCLIQUES

  摘要：

  式I的化合物及其药用盐，其中Ar和R如规范中所定义，含有这种化合物的组合物以及这种化合物和组合物在治疗中的用途。

  公开号：

  WO2003087104A1

文献信息

• [EN] IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH<br/>[FR] DÉRIVÉS IMIDAZOLE UTILES COMME INHIBITEURS DE LA FAAH
  申请人：MERCK & CO INC

  公开号：WO2009152025A1

  公开（公告）日：2009-12-17

  The present invention is directed to certain imidazole derivatives which are useful as inhibitors of Fatty Acid Amide Hydrolase (FAAH). The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including osteoarthritis, rheumatoid arthritis, diabetic neuropathy, postherpetic neuralgia, skeletomuscular pain, and fibromyalgia, as well as acute pain, migraine, sleep disorder, Alzeimer Disease, and Parkinson's Disease.

  本发明涉及某些咪唑衍生物，其可用作脂肪酰胺水解酶（FAAH）的抑制剂。该发明还涉及包含这些化合物作为活性成分的药物配方，以及这些化合物及其配方在治疗某些疾病中的使用，包括骨关节炎、类风湿性关节炎、糖尿病性神经病、带状疱疹后神经痛、骨骼肌肉疼痛和纤维肌痛，以及急性疼痛、偏头痛、睡眠障碍、阿尔茨海默病和帕金森病。
• [EN] PYRROLOTRIAZINONE DERIVATIVES AS PI3K INHIBITORS<br/>[FR] DÉRIVÉS DE PYRROLOTRIAZINONE EN TANT QU'INHIBITEURS DES PI3K
  申请人：ALMIRALL SA

  公开号：WO2014060432A1

  公开（公告）日：2014-04-24

  New pyrrolotriazinone derivatives having the chemical structure of formula (I), are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Phosphoinositide 3-Kinases (PI3Ks)

  新的吡咯三唑酮衍生物具有化学结构式（I），公开；以及它们的制备方法，包括它们的药物组合物和它们作为磷脂酰肌醇3-激酶（PI3Ks）抑制剂在治疗中的应用。
• [EN] 1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS<br/>[FR] 1H-PYRAZOLO [4,3-B] PYRIDINES EN TANT QU'INHIBITEURS DE PDE1
  申请人：H LUNDBECK AS

  公开号：WO2018007249A1

  公开（公告）日：2018-01-11

  The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.

  本发明提供了式(I)的1H-吡唑并[4,3-b]吡啶-7-胺作为PDE1抑制剂，并将其用作药物，特别用于治疗神经退行性疾病和精神疾病。
• MACROCYCLES AS PDE1 INHIBITORS
  申请人：H. Lundbeck A/S

  公开号：US20190185489A1

  公开（公告）日：2019-06-20

  The present invention provides macrocycles of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.

  本发明提供了式(I)的大环化合物作为PDE1抑制剂，并将其用作药物，特别用于治疗神经退行性疾病和精神疾病。
• 1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS
  申请人：H. Lundbeck A/S

  公开号：US20190194189A1

  公开（公告）日：2019-06-27

  The present invention provides 1H-pyrazolo[4,3-b]pyridines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.

  本发明提供了式(I)的1H-吡唑并[4,3-b]吡啶类化合物作为PDE1抑制剂，并将其用作药物，特别用于治疗神经退行性疾病和精神疾病。